- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Small Cap High Growth Stocks
Global Pharmaceuticals & Biotech Small Cap High Growth Stocks
UPDATED Jul 03, 2022
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
531 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| XSPRAYXspray Pharma | kr54.20 | -1.5% | -47.5% | kr1.1b | n/a | PB2x | E98.5% | n/a | ||
| 4572Carna Biosciences | JPÂ¥879.00 | -3.3% | -43.5% | JPÂ¥12.0b | n/a | PS5.1x | E78.1% | n/a | ||
| CUVClinuvel Pharmaceuticals | AU$15.93 | -1.2% | -44.2% | AU$751.0m | AU$27.57 | PE32.6x | E29.4% | 0.2% | ||
| 2552Hua Medicine (Shanghai) | HK$3.82 | -0.5% | -13.6% | HK$3.6b | HK$9.66 | PS484.7x | E90.8% | n/a | ||
| HYLHyloris Pharmaceuticals | €14.16 | -2.3% | 6.5% | €379.5m | €20.25 | PS122.6x | E77.4% | n/a | ||
| CNWco.don | €0.63 | 61.5% | -80.1% | €13.8m | €6.30 | PS2.1x | E74.2% | n/a | ||
| ALDVIAdvicenne | €5.55 | 3.5% | -25.0% | €55.1m | €16.90 | PS14.8x | E101.6% | n/a | ||
| ALVALValbiotis | €6.12 | -0.6% | -8.8% | €59.5m | €14.70 | PS199.7x | E100.7% | n/a | ||
| AZTArcticZymes Technologies | kr79.35 | -0.06% | -14.7% | kr4.0b | kr132.00 | PE83.5x | E34.1% | n/a | ||
| GENOGenovis AB (publ.) | kr46.10 | 2.6% | 4.8% | kr3.0b | kr80.00 | PE82.9x | E55.6% | n/a | ||
| 2160GNI Group | JPÂ¥1,227.00 | -3.9% | -38.9% | JPÂ¥58.5b | JPÂ¥2,100.00 | PE59.1x | E31.0% | n/a | ||
| NEUNeuren Pharmaceuticals | AU$3.72 | -1.6% | 125.5% | AU$471.1m | AU$6.14 | PS146.6x | E38.7% | n/a | ||
| EGTXEgetis Therapeutics | kr4.27 | 15.7% | -24.3% | kr916.3m | kr16.50 | PS22x | E79.9% | n/a | ||
| MDPMedexus Pharmaceuticals | CA$1.96 | 1.6% | -73.5% | CA$39.1m | CA$6.50 | PB1.7x | E88.3% | n/a | ||
| EXPRS2ExpreS2ion Biotech Holding | kr11.89 | -0.8% | -71.0% | kr439.9m | kr86.00 | PS31.7x | E81.9% | n/a | ||
| PHOPhotocure | kr103.30 | 0.2% | -25.3% | kr2.8b | kr145.00 | PS7.9x | E105.3% | 0% | ||
| MITRAMithra Pharmaceuticals | €6.95 | -17.1% | -69.1% | €347.2m | €25.43 | PS15.3x | E83.0% | 0% | ||
| HGENHumanigen | US$1.64 | -24.8% | -90.4% | US$115.8m | US$16.43 | PS27.9x | E59.5% | n/a | ||
| ULTIUltimovacs | kr72.00 | 2.1% | -1.9% | kr2.5b | kr151.00 | PB4.4x | E33.6% | n/a | ||
| NWRNNewron Pharmaceuticals | CHF1.45 | -5.2% | -43.1% | CHF25.9m | CHF9.25 | PS4.5x | E54.6% | n/a | ||
| IVACCIntervacc | kr41.50 | -5.9% | -46.0% | kr2.1b | kr96.00 | PS233.6x | E86.4% | n/a | ||
| ISOFOLIsofol Medical | kr7.85 | -0.6% | -14.3% | kr1.3b | kr23.33 | PS59.8x | E103.6% | n/a | ||
| KZAKazia Therapeutics | AU$0.61 | -0.8% | -55.3% | AU$85.3m | AU$1.90 | PS5.6x | E59.5% | n/a | ||
| ALONCOncodesign Société Anonyme | €9.17 | 9.0% | -11.1% | €62.7m | €16.55 | PS1.7x | E50.6% | n/a |